The most common‐used GC tumour markers, including carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 199, CA242 and CA724, are not sensitive or specific enough for GC screening and diagnosis, particularly for the early GC patients.4, 5. The gene discussed is CEACAM5; the disease is neoplasm.